Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Manufacturers Argue FDA Sunscreen Reviews Keep Outside Science In Shadow

This article is powered by The Rose Sheet

Executive Summary

FDA officials and the Public Access to Sunscreen Coalition will meet Nov. 1 in effort to find common ground between FDA and outside scientists on standards for testing requirements of new sunscreens under one of four draft guidances the agency is scheduled to finalize by the end of the year.


Related Content

Industry Groups To Request FDA Rulemaking Deferrals For Sunscreen Ingredients In Question
FDA Sunscreen Guidance: Absorption Data Is A MUsT For GRASE Review
Sunscreen Group Remains Cloudy About FDA's Ingredient Evaluations
Sunscreen Guidances Underscore FDA Standards Aren’t Changing
FDA's Sunscreen Data Guidance Lacks Risk/Benefit Balance – Stakeholders
FDA Drafts Guidance On Safety-Data Musts For GRASE Sunscreen Actives
FDA Seeks Comment On Proposed Orders Under Sunscreen Innovation Act


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts